HALO
Halozyme Therapeutics Inc
Price:  
58.29 
USD
Volume:  
905,623.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HALO Relative Valuation

104.9%
Upside

As of 2025-02-17, the Relative Valuation of Halozyme Therapeutics Inc (HALO) is 119.43 USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.29 USD, the upside of Halozyme Therapeutics Inc based on Relative Valuation is 104.9%.

The range of the Relative Valuation is 87.74 - 154.54 USD.

Range Selected
Trailing P/E multiples 38.2x - 50.1x 44.2x
Forward P/E multiples 32.0x - 42.9x 37.4x
Fair Price 87.74 - 154.54 119.43
Upside 50.5% - 165.1% 104.9%
58.29 USD
Stock Price
119.43 USD
Fair Price

HALO Relative Valuation - Historical P/E Data

Date P/E
2025-02-14 18.90
2025-02-13 19.00
2025-02-12 18.84
2025-02-11 18.59
2025-02-10 18.59
2025-02-07 18.51
2025-02-06 18.78
2025-02-05 18.68
2025-02-04 18.40
2025-02-03 18.24
2025-01-31 18.36
2025-01-30 18.29
2025-01-29 18.10
2025-01-28 18.15
2025-01-27 18.11
2025-01-24 18.08
2025-01-23 18.03
2025-01-22 17.92
2025-01-21 18.13
2025-01-17 17.77
2025-01-16 17.95
2025-01-15 17.67
2025-01-14 17.45
2025-01-13 17.55
2025-01-10 17.12
2025-01-08 17.43
2025-01-07 16.59
2025-01-06 16.37
2025-01-03 15.48
2025-01-02 15.56
2024-12-31 15.50
2024-12-30 15.56
2024-12-27 15.60
2024-12-26 15.57
2024-12-24 15.41
2024-12-23 15.29
2024-12-20 15.22
2024-12-19 15.34
2024-12-18 15.18
2024-12-17 15.76
2024-12-16 15.57
2024-12-13 15.56
2024-12-12 15.51
2024-12-11 15.36
2024-12-10 15.90
2024-12-09 15.90
2024-12-06 15.69
2024-12-05 15.58
2024-12-04 15.76
2024-12-03 15.72